Ensign Peak Advisors
ALIM

Ensign Peak Advisors’s Alimera Sciences ALIM Stock Holding History

Ensign Peak Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,151
Closed -$81K – 2255
2021
Q3 		$81K Buy
+19,151
New +$134K ﹤0.01% 1813

Other funds holding ALIM

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's ALIM Position: Q4 2021 in Review

Ensign Peak Advisors sold out of Alimera Sciences (ALIM) in Q4 2021, closing a stake of 19,151 shares — an estimated $81K sold.

Ensign Peak Advisors first reported a position in ALIM in Q3 2021 and held it in 1 quarter. The position peaked at $81K in Q3 2021. 21 funds tracked by Wall St. Rank hold ALIM as of Q4 2021.

  • Ensign Peak Advisors reported no remaining Alimera Sciences position as of Q4 2021 after selling out during the quarter.
  • Ensign Peak Advisors sold 19,151 Alimera Sciences shares in Q4 2021, an estimated $81K.
  • Ensign Peak Advisors first reported a position in Alimera Sciences in Q3 2021 and held it in 1 quarter.
  • Ensign Peak Advisors's Alimera Sciences position peaked at $81K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2021.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.